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Submitted Oct 31, 2013; accepted Jan 20, 2014.DISCUSSIONDr Peter Lawrence (Los Angeles, Calif). Would you address
the issue of the tiny patient who has unilateral limb ischemia and
a very small femoral artery? I noticed that there are very few in
that operative category. When do you explore the artery and
when do you use a microscope? What kind of catheters do you
use to extract the clot?
Dr Ahmed Kayssi. We had a 1-day-old patient in our series
who was born with a congenital abnormality requiring catheteriza-
tion. Unfortunately, he was taken to the operating room by our
colleagues in cardiac surgery, and we could not ﬁnd an operative
note in his chart; so, I can’t comment on the technical aspects of
that case.
Dr Lawrence. Is that because you avoid operating on babies
below a certain femoral artery size? What would be your approach
to the baby who still has an acutely ischemic limb after removal of
an umbilical artery catheter and has a tiny common femoral
artery?
Dr Kayssi. I don’t have the answer to that question. The
Hospital for Sick Children does not have a dedicated vascular sur-
gery service and so they call upon the vascular surgeons from across
the street at Toronto General Hospital to provide coverage on an
as-needed basis. I don’t know what my colleagues’ operative
approach to a neonate would be.
Dr Linda Harris (Buffalo, NY). Do you differentiate your
plans for intervention based on whether they are traumatic or iat-
rogenic? What do you use as your indication for intervention? I
would agree with anticoagulation, especially in the very young chil-
dren. Is there an age at which you would say you go to the oper-
ating room sooner or intervene sooner? Obviously, the young
infants have very tiny vessels and don’t respond as well to surgical
interventions, but what if you have a 10-year-old or a 12-year-old,
are you faster to the operating room?
Dr Kayssi. There is no difference in our management proto-
col according to age. Our treatment protocol is based on giving
the patient a trial of anticoagulation ﬁrst with unfractionated or
low-molecular-weight heparin, unless there is obvious evidenceof tissue loss, in which case those patients are taken to the oper-
ating room immediately.
If at 24 hours there is no clinical or ultrasound evidence of clot
resolution, than a course of tissue plasminogen activator would be
considered, unless contraindicated. In our nine patients who
received tPA, in seven instances the tPA course was successful.
Two patients, however, did require an operative intervention after
failing tPA.
Dr James Stanley (Ann Arbor, Mich). I have one question
and one admonition. The fact that approximately a third of your
patients were under the age of 30 days raises the question as to
whether these children developed their limb ischemia as a conse-
quence of an umbilical artery catheterization that became a focus
of a thrombotic or embolic event. My speciﬁc question relates to
what percentage of neonates undergoing umbilical catheterization
at the Hospital for Sick Children develop altered lower extremity
blood ﬂow, be it symptomatic or not. The frequency of this
even has been poorly documented in the literature.
Dr Kayssi. That’s a great question, sir. We did not look for
that in the data set.
Dr Stanley. Many infants and young children with acute cath-
eter-based external iliac or femoral arterial occlusions develop robust
collaterals to the affected extremity. In fact, they often have easily
palpable distal pulses, may have normal resting ankle-brachial
indices, and some do not have an exercise-related drop in their
ankle-brachial index because of the very minimal resistance in these
large collateral channels. Unfortunately, as the child becomes older,
the affected limb may exhibit long-bone growth retardation. If the
ensuing limb-length discrepancy goes unrecognized and untreated,
the outcome may be very disabling. This subject was addressed
2 days ago at this meeting when we presented the University of
Michigan’s recent experience with 28 preadolescent children having
lower extremity ischemia that required operative intervention. My
admonition is that many pediatric patients with acute limb ischemia
need careful long-term follow-up if chronic problems are to be
avoided. Their initial management is only a part of their care.
